It was an extraordinary week. Unfortunately, it also represents a market where price action, investor sentiment, and consumer sentiment have deteriorated from bad to worse. However, there's still room for hope.
The furniture industry is facing challenges due to economic uncertainty and declining consumer confidence. However, two companies are navigating these challenges by investing in technological advancements, product innovation, and cost efficiency.
Lepodisiran is being developed by biotech giant Eli Lilly & Co. Here’s the tale of this new drug, how it could help millions, and how this furthers the “less-is-more” strategy that will make Lilly the “King of the Mountain” in biotech.
As tariffs hit, markets tremble. Stocks slide, volatility spikes, and investors scramble. It’s a pattern we’ve seen before — and it’s playing out again.
Several companies have delayed their upcoming initial public offerings or have been considering doing so as President Trump's aggressive tariffs continued to roil global financial markets. Examples include Klarna, StubHub, and Chime.
The big, overleveraged and overexposed investors, who held their positions over the past several weeks, are now trapped with huge losses after the recent market crash.
Mark Cuban is a billionaire and has shared many pieces of business advice over the years. One interview saw Cuban lay out four rules to becoming a millionaire.
